# US 2004/0081990 A1 · Method for the identification of essential genes and therapeutic targets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081990 A1
- Document ID: US20040081990A1
- Status: Published application
- Kind: A1
- Application number: 10/647,566
- Filed: 2003-08-25
- Published: 2004-04-29
- Earliest claimed: 1997-09-19
- Assignees: Universite Laval
- Inventors: Roger C. Levesque; Francois Sanschagrin; Guy Cardinal
- Web page: https://patentgrep.com/patent/US20040081990A1

## CPC

- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/1034: {Isolating an individual clone by screening libraries}
- C12Q 1/6858: Allele-specific amplification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method of identifying essential genes in a genome, based on an insertional mutagenesis of a population of cells or of DNA molecules and subjecting this population of cells or DNA molecules to an amplification process, whereby this total population of cells or DNA molecules which statistically represents at least one full insertionally mutated genome is amplified with at least two primer pairs and the extension products analysed, in order to distinguish essential genes from dispensable genes. The present invention is especially suited to the functional analysis of microbial genomes, and especially to haploid genomes.

## Claims

### Claim 1

A method for identifying essential and non-essential genes in a genome of a cell grown in non-selective conditions, said method comprising:
saturation mutagenesis of said genome by insertion mutagenesis, whereby an oligonucleotide sequence is inserted in the target regions of said genome such that a population of cells having at least 90% of said target regions insertionally mutated is obtained;
growing said population of cells under non-selective conditions to provide a non-selected sub-population of cells;
amplifying a target region from said non-selected sub-population of cells, using a first primer which hybridizes to a known first end of said target region, and a second primer which hybridizes to another known end of said target region, said first and second primers thereby constituting a first primer pair, giving rise to a first extension product, and a third primer which hybridizes to said oligonucleotide sequence, said third primer constituting a second primer pair with one said first or second primer, said second primer pair enabling the amplification of a second extension product; and
assessing for the presence or absence of said first and second extension product, whereby the presence of the first and second extension products is indicative of a non-essential gene, whereas the presence of the first extension product and the absence of the second extension product is indicative of an essential gene.

### Claim 2 (depends on 1)

A method according to claim 1, wherein mutagenizing is performed with a transposable element.

### Claim 3 (depends on 2)

A method according to claim 2, wherein said target DNA comprises a gene encoding a protein.

### Claim 4

A method for functional analysis of a target region in a sequence of interest, said method comprising:
mutagenizing said target region by insertion of a sequence tag to provide a population of DNA molecules containing a sequence tag insertion in at least 90% of nucleotide positions in said target region;
introducing said population of mutagenized DNA molecules into host cells that express said sequence of interest;
subjecting a first aliquot of said host cells to at least one selective condition and a second aliquot to a non-selective condition to provide at least one selected and one non-selected aliquot;
amplifying said target region from said at least one selected and one non-selected aliquots, using a first primer hybridizing to said sequence tag and a second primer hybridizing to a known endpoint, said endpoint being characterized as an arbitrary unique sequence in said target DNA, to provide amplified DNA; and
resolving by gel electrophoresis said amplified DNA from said at least one selected and one non-selected aliquots into individual bands differing by size to identify the position of individual sequence tag insertions within said target region,
whereby differences between the presence or intensity of bands between said at least one selected and one non-selected aliquots are indicative that said sequence tag insertion causes a difference in response to said selective condition employed with said at least one selected aliquot resulting in the functional analysis of said target region.

### Claim 5 (depends on 4)

A method according to claim 4, wherein mutagenizing comprises the steps of:
combining DNA comprising said target region with retroviral integrase and a first set of complementary oligonucleotide primers, said primers comprising (a) a recognition sequence for said retroviral integrase and (b) a sequence tag, wherein said retroviral integrase mediates the insertion of said first set of complementary oligonucleotide primers to provide a population of mutagenized DNA molecules.

### Claim 6 (depends on 4)

A method according to claim 4, wherein mutagenizing comprises the steps of:
combining DNA comprising said target region with retroviral integrase and a first set of complementary oligonucleotide primers, said primers comprising (a) a recognition sequence for said retroviral integrase and (b) a recognition site for a type IIs restriction endonuclease, wherein said retroviral integrase mediates the insertion of said first set of complementary oligonucleotide primers to provide a population of mutagenized DNA molecules
cutting said population of mutagenized DNA molecules with said type Ils restriction endonuclease to provide cut DNA; and
ligating to said cut DNA a second set of complementary oligonucleotide primers comprising a sequence tag.

### Claim 7 (depends on 5)

A method according to claim 5, wherein said sequence of interest comprises a gene encoding a protein.

### Claim 8 (depends on 4)

A method according to claim 4, wherein said selective condition is growth of cells in media lacking a nutrient that is an intermediate in a metabolic pathway.

### Claim 9 (depends on 8)

A method according to claim 8, wherein said population of mutagenized DNA molecules are cloned into a filamentous bacteriophage vector with regulatory sequences for expression of said sequence of interest.

### Claim 10 (depends on 5)

A method according to claim 5, wherein said sequence of interest comprises a regulatory gene.

### Claim 11 (depends on 10)

A method according to claim 10, wherein said selective condition is growth in media containing a cytotoxic agent, and said regulatory gene controls expression of a gene conferring resistance to said cytotoxic agent.

### Claim 12 (depends on 4, 5, 6, 7, 8, 9, 10, 11)

A method according to one of claims 4 to 11, whereby the absence of a band under said selective condition and its presence under non-selective conditions is indicative of a target region which is essential under said selective condition.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

A method according to one of claims 1-12, wherein said genome is a haploid genome.

### Claim 14 (depends on 13)

A method according to claim 13, wherein said haploid genome is a bacterial genome.

### Claim 15

A method for identifying essential genes in a genome of a cell grown in non-selective conditions, said method comprising:
saturation mutagenesis of said genome by insertion mutagenesis, whereby an oligonucleotide sequence is inserted in the target regions of said genome such that a population of cells having at least 90% of said target regions insertionally mutated is obtained;
growing said population of cells under non-selective conditions to provide a non-selected sub-population of cells;
amplifying a target region from said non-selected sub-population of cells, using a first primer which hybridizes to a known end of said target region, and a second primer which hybridizes to said oligonucleotide sequence, said first and second primers constituting a primer pair capable of giving rise to an amplification of an extension product when said oligonucleotide sequence is inserted into said target region; and
assessing for the presence or absence of said first and second extension product, whereby the presence thereof is indicative of a non-essential gene, whereas the absence thereof is indicative of an essential gene.

### Claim 16

A method for identifying essential genes in a genome of a cell comprising:
saturation mutagenesis of said genome by insertion mutagenesis, whereby an oligonucleotide sequence is inserted in the target regions of said genome such that a population of cells having at least 90% of said target regions insertionally mutated is obtained;
growing said population of cells under selective or non-selective conditions to provide a selected or non-selected sub-population of cells;
amplifying a target region from said sub-population of cells, using a first primer which hybridizes to a known first end of said target region, and a second primer which hybridizes to another known end of said target region, said first and second primers thereby constituting a first primer pair, giving rise to a first extension product, and a third primer which hybridizes to said oligonucleotide sequence, said third primer constituting a second primer pair with one said first or second primer, said second primer pair enabling the amplification of a second extension product; and
assessing for the presence or absence of said first and second extension product, whereby the presence of the first and second extension products is indicative of a non-essential gene, whereas the presence of the first extension product and the absence of the second extension product is indicative of an essential gene.

### Claim 17 (depends on 16)

A method according to claim 16, wherein said genome is a haploid genome.

### Claim 18 (depends on 16, 17, 18)

A method according to claim 16 to 18, wherein insertion mutagenesis is carried out with a transposable element.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

A method according to one of claims 1-18, wherein said amplification is carried out by the polymerase chain reaction.

### Claim 20

A method for identifying a therapeutic target in a genome of a cell grown in non-selective conditions, said method comprising:
saturation mutagenesis of said genome by insertion mutagenesis, whereby an oligonucleotide sequence is inserted in the target regions of said genome such that a population of cells having at least 90% of said target regions insertionally mutated is obtained;
growing said population of cells under non-selective conditions to provide a non-selected sub-population of cells;
amplifying a target region from said non-selected sub-population of cells, using a first primer which hybridizes to a known first end of said target region, and a second primer which hybridizes to another known end of said target region, said first and second primers thereby constituting a first primer pair, giving rise to a first extension product, and a third primer which hybridizes to said oligonucleotide sequence, said third primer constituting a second primer pair with one said first or second primer, said second primer pair enabling the amplification of a second extension product; and
assessing for the presence or absence of said first and second extension product, whereby the presence of the first extension product and the absence of the second extension product is indicative of an essential gene and hence of an identification of a therapeutic target in said cell.
